| 14-May-13 07:31AM | PSIVIDA CORP. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 13-May-13 07:57PM | pSivida Corp's CEO Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 04:00PM | pSivida Corp. Reports Third Quarter Fiscal Year 2013 Results Business Wire |
| 09:05AM | PSIVIDA CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 07:07AM | Q3 2013 pSivida Corp. Earnings Release - After Market Close CCBN |
| 06:57AM | Alimera Sciences And Trius Therapeutics: 2 Big Biotechs For 2013 at Seeking Alpha |
| 07-May-13 04:14PM | InPlay: pSivida announces commercial launch of ILUVIEN in Germany with first patient treated Briefing.com |
| 04:14PM | pSivida Corp. Announces Commercial Launch of ILUVIEN® in Germany with First Patient Treated Business Wire |
| 06-May-13 04:40PM | pSivida Corp. Announces Third Quarter 2013 Financial Results Release Date and Conference Call Information Business Wire |
| 03:32PM | Ophthalmology: A Niche Where Innovation Pays at Seeking Alpha |
| 02-May-13 02:07PM | 5 Stocks Under $10 Set to Surge at TheStreet +9.36% |
| 01-May-13 08:03AM | InPlay: pSivida announces new ILUVIEN PDUFA date of October 17, 2013 Briefing.com |
| 08:01AM | pSivida Corp. Announces New ILUVIEN® PDUFA Date of October 17, 2013 Business Wire |
| 29-Apr-13 07:44AM | pSivida Reports ILUVIEN® Available in UK Business Wire |
| 24-Apr-13 03:04AM | For Iluvien, The FDA Isn't The Issue; European Sales Are at Seeking Alpha |
| 17-Apr-13 11:02AM | pSivida Corp. President and CEO, Dr. Paul Ashton Publishes Blog Post Titled ''Transformational Change and Ophthalmology'' Accesswire |
| 10-Apr-13 02:00PM | IBM is a Buy and 3 More Analyst Upgrades to Know Now at Wall St. Cheat Sheet |
| 08:00AM | pSivida Announces Launch of New Online Corporate Communication Channels Business Wire |
| 12:55AM | pSivida upgraded by Ladenburg Thalmann Briefing.com |
| 04-Apr-13 02:28PM | Is The Third Time The Charm For ILUVIEN? at Seeking Alpha |
| 07:30AM | pSivida Announces Tech Evaluation Agreement With Leading Global Pharmaceutical Company Business Wire |
| 01-Apr-13 09:15AM | InPlay: pSivida reports on resubmission to FDA of NDA for ILUVIEN for chronic diabetic macular edema Briefing.com |
| 09:15AM | pSivida Reports on Resubmission to FDA of NDA for ILUVIEN® for Chronic Diabetic Macular Edema Business Wire |
| 27-Mar-13 11:20AM | pSivida Corp - Transformational Change via Strategic Drug Delivery Accesswire |
| 22-Mar-13 08:01AM | InPlay: pSivida reports updates on ILUVIEN for planned resubmission to fda and European Launch Briefing.com |
| 08:00AM | pSivida Reports Updates on ILUVIEN® for Planned Resubmission to FDA and European Launch Business Wire |
| 01:12AM | PSIVIDA CORP. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 20-Mar-13 01:15PM | pSivida VP of Research to Discuss Companys Protein and Antibody Sustained Delivery System at 5th Ocular Diseases and Drug Development Conference Business Wire |
| 27-Feb-13 07:55AM | Changing Trends in the Drug Delivery Industry Accesswire |
| 13-Feb-13 01:04PM | PSIVIDA CORP. Financials EDGAR Online Financials |
| 08-Feb-13 11:11AM | PSIVIDA CORP. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 06-Feb-13 09:21PM | pSivida Corporation's CEO Discusses F3Q13 Results - Earnings Call Transcript at Seeking Alpha |
| 04:01PM | PSIVIDA CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 04:00PM | pSivida Corp. Reports Second Quarter Fiscal Year 2013 Results Business Wire |
| 07:07AM | Q2 2013 pSivida Corp. Earnings Release - After Market Close CCBN |
| 04-Feb-13 11:45AM | pSivida CEO to Present at 15th Annual BioCEO & Investor Conference February 12 Business Wire |
| 30-Jan-13 04:00PM | pSivida Corp. Announces Second Quarter 2013 Financial Results Release Date and Conference Call Information Business Wire |
| 23-Jan-13 07:31AM | Psivida Corp. Announces Final Published Guidance from U.K.s Nice and Pursuit of Patient Access Scheme for Iluvien® for DME Business Wire |
| 17-Jan-13 07:31AM | pSivida Corp. Announces Spain Grants ILUVIEN® Marketing Approval for Chronic Diabetic Macular Edema Business Wire |
| 18-Dec-12 02:37PM | PSIVIDA CORP. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online +7.41% |
| 29-Nov-12 07:27PM | pSivida Corp. Reports Patient Access Scheme Being Developed by Alimera to Address Cost Concerns Following Negative Final Draft Guidance by U.K.s NICE for ILUVIEN® for DME Business Wire |
| 16-Nov-12 01:04PM | PSIVIDA CORP. Financials EDGAR Online Financials |
| 10-Nov-12 09:30AM | New Star Analyst Rankings for pSivida Corp. StarMine |
| 09-Nov-12 05:30PM | pSivida Gets FDA Clearance, Pozen gets Upgrade: Healthcare Business Update at Wall St. Cheat Sheet |
| 02:04PM | PSIVIDA CORP. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 09:32AM | New Star Analyst Rankings for pSivida Corp. StarMine |
| 08-Nov-12 09:12PM | pSivida's CEO Discusses F1Q13 Results - Earnings Call Transcript at Seeking Alpha -7.19% |
| 04:30PM | pSivida Corp. Earnings Call scheduled for 4:30 pm ET today CCBN |
| 04:17PM | pSivida Corp. Earnings Call scheduled for 4:30 pm ET today CCBN |
| 04:01PM | PSIVIDA CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 04:00PM | pSivida Corp. Reports First Quarter Fiscal Year 2013 Results Business Wire |
| 07:37AM | pSivida Corp. Earnings Call scheduled for 4:30 pm ET today CCBN |
| 07:07AM | Q1 2013 pSivida Corp. Earnings Release - Time Not Supplied CCBN |
| 04:17AM | pSivida Corp. Earnings Call scheduled for 4:30 pm ET today CCBN |
| 06-Nov-12 03:16AM | 3 Dirt Cheap Drug Companies About To Make A Comeback at Seeking Alpha |
| 01-Nov-12 04:45PM | pSivida Corp Announces First Quarter 2013 Financial Results Release Date and Conference Call Information Business Wire |
| 15-Oct-12 09:00AM | pSivida CEO to Discuss Sustained Delivery and Nanotechnology in Ophthalmology at Upcoming Massachusetts Biotechnology Council Meeting Business Wire |
| 08:11AM | 5 Healthcare Companies With Insider Buying During October 2012 at Seeking Alpha |
| 03-Oct-12 01:04PM | PSIVIDA CORP. Financials EDGAR Online Financials |
| 27-Sep-12 05:28PM | PSIVIDA CORP. Files SEC form 10-K, Annual Report EDGAR Online |
| 25-Sep-12 09:56AM | New Star Analyst Rankings for pSivida Corp. StarMine |
| 24-Sep-12 08:38PM | pSivida's CEO Discusses F4Q2012 Results - Earnings Call Transcript at Seeking Alpha |
| 04:02PM | PSIVIDA CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 04:00PM | pSivida Corp. Reports Fourth Quarter and Fiscal Year 2012 Results Business Wire |
| 07:07AM | Q4 2012 pSivida Corp. Earnings Release - After Market Close CCBN |
| 17-Sep-12 12:30PM | pSivida Corp. Announces Fourth Quarter and Fiscal Year 2012 Financial Results Release Date and Conference Call Information Business Wire |
| 05-Sep-12 08:44AM | InPlay: pSivida reports U.K. National Institute for Health and Clinical Evidence accepts ILUVIEN subgroup data for review Briefing.com |
| 08:41AM | pSivida Corp. Reports U.K. National Institute for Health and Clinical Evidence Accepts ILUVIEN® Subgroup Data for Review Business Wire |
| 29-Aug-12 09:00AM | pSivida CEO to Discuss Sustained Delivery and Nanotechnology in Ophthalmology at Drug Delivery Technologies & Formulation Conference in Switzerland Business Wire |
| 28-Aug-12 09:00AM | pSivida to Present at Two Investment Conferences in September Business Wire |
| 08-Aug-12 12:45PM | pSivida Corp. Announces Closing of $5.36 Million Registered Direct Financing Business Wire -18.66% |
| 07-Aug-12 07:01PM | Alimeras Iluvien Fails to Win Backing From U.K. Cost Agency at Bloomberg |
| 03-Aug-12 07:56AM | Healthcare Business Rewind: Gilead COLLABORATES, pSivida DIVESTS at Wall St. Cheat Sheet |
| 02-Aug-12 09:34AM | PSIVIDA CORP. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online -13.33% |
| 09:09AM | InPlay: pSivida announces $5.36 mln registered direct financing Briefing.com |
| 09:08AM | pSivida raises $5.36M in registered direct offering at theflyonthewall.com |
| 09:05AM | pSivida Corp. Announces $5.36 Million Registered Direct Financing Business Wire |
| 01-Aug-12 04:30PM | PSIVIDA CORP. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online -13.04% |
| 08:15AM | InPlay: pSivida reports Alimera's intention to resubmit application to FDA for ILUVIEN in DME using data from completed trials Briefing.com |
| 08:15AM | pSivida Corp. Reports Alimeras Intention to Resubmit Application to FDA for ILUVIEN® in DME Using Data from Completed Trials Business Wire |
| 30-Jul-12 11:24PM | Healthcare review: Progenics & Salix Slump On FDA, pSivida & Vermillion Jump Thomson Reuters ONE +6.52% |
| 09:15AM | pSivida Corp. Announces Tech Evaluation Agreement for Tethadur Protein/Antibody Delivery System with Leading Biopharmaceutical Company Business Wire |
| 27-Jul-12 07:50AM | Friday's BioPharma Watch List: Amarin's Vascepa Approval - What This Now Means at Seeking Alpha +15.48% |
| 26-Jul-12 12:48PM | Roches Lucentis Backed by FDA Panel for Diabetic Blindness at Bloomberg |
| 08:27AM | InPlay: pSivida announces Germany grants ILUVIEN marketing authorization for the treatment of chronic diabetic macular edema Briefing.com |
| 08:25AM | pSivida Corp. Announces Germany Grants ILUVIEN® Marketing Authorization for the Treatment of Chronic Diabetic Macular Edema Business Wire |
| 24-Jul-12 02:16PM | 4 Stocks Under $10 Making Big Moves at TheStreet +7.36% |
| 20-Jul-12 06:10PM | Nasdaq stocks posting largest volume increases AP -12.04% |
| 08:04AM | Healthcare Business Review: pSividas CURES Blindness, Baxters DUTCH Deal at Wall St. Cheat Sheet |
| 04:22AM | 5 Rally Stocks: 2 To Buy, 2 To Sell, And 1 To Watch at Seeking Alpha |
| 19-Jul-12 08:09PM | Healthcare Business Review: pSividas New Blindness CURE, Baxters DUTCH Deal at Wall St. Cheat Sheet +28.04% |
| 06:29PM | Nasdaq stocks posting largest volume increases AP |
| 02:20PM | Healthcare Review: Anthera Pharmaceuticals Jumps, pSivida Corp and Verisante Technology Move On News Developments Thomson Reuters ONE |
| 12:24PM | PSIVIDA CORP. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Fina EDGAR Online |
| 09:46AM | Psivida eye device to move to late-stage trials, shares up at Reuters |
| 08:15AM | InPlay: pSivida receives FDA clearance for pivotal trials for injectable sustained-release micro-insert to treat uveitis Briefing.com |
| 18-Jul-12 03:53PM | PSIVIDA CORP. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 11:15AM | pSivida Corp. Announces France Grants ILUVIEN® Marketing Authorization for the Treatment of Chronic Diabetic Macular Edema Business Wire |
| 09:45AM | pSividas Partner Alimera Sciences Announces an Agreement to Raise Capital to Fund the Development and Commercialization of ILUVIEN® Business Wire |
| 29-Jun-12 12:44PM | 5 Stocks Poised for Breakouts at TheStreet |
